Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)

Completed · Phase 4 · Has a placebo group

Conditions studied: Alcoholism, Smoking

In brief

The purpose of this study is to determine the effectiveness of naltrexone (Revia) or matched placebo combined with nicotine patch (Nicotrol) or placebo patch using a 2x2 design in reducing drinking and smoking in patients with both nicotine and alcohol dependence.

Key facts

Study ID
NCT00000437
Run by
The Scripps Research Institute
People needed
60
Starts
1997-09-26
Expected to finish
2005-09-15
Last updated by the study team
2017-04-20

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.